431-440 of 538 results for 'consumer data right'

ALRC recommends broad changes to Australia's corporate criminal responsibility regime
Insight 08 Sep 2020

The ALRC is proposing an ambitious reform agenda to recalibrate the role that federal criminal law plays in the overall regulation of companies and better align corporate criminal liability with corporate culpability. Read our latest insight for our analysis on the report. ...

The COVID-19 pandemic – what employers in Vietnam need to know
Insight 01 Apr 2020

The Covid-19 pandemic is not only a health crisis in the global community, but has caused widespread economic disruption to all companies and governments around the world. As have governments in other countries, the Government of Vietnam has issued various restrictions and regulations ...

Roadblocks remain for design protection of Graphical User Interfaces in Australia
Insight 12 Aug 2025

Two recent decisions by IP Australia have confirmed that Graphical User Interfaces (GUIs) are not certifiable as designs under the Designs Act, due to their transient nature and IP Australia's narrow ...

FIRB changes to note from 1 July 2023
Insight 29 Jun 2023

In this Insight, we outline and comment on the New Register and corresponding reporting obligations. ...

The pitfalls of pre-emptive rights
Insight 04 Jun 2023

In this Insight, we consider an alternative approach that may better balance the rights of selling and non-selling investors where a pre-emptive right remains appropriate. ...

National Electricity and Gas rules update: January 2025
Insight 13 Feb 2025

In our latest update, we examine the progress of new and existing rule change requests to the AEMC across the month of January and take a closer look at the AEMC Reliability Panel's review of the System Restart Standard.  ...

Patent term extensions under siege: a new era of challenges for pharmaceutical patentees
Insight 24 Nov 2024

A recent Federal Court decision has struck down a patent term extension granted to Novartis for its blockbuster heart failure drug Entresto. The decision in Novartis AG v Pharmacor Pty Limited follows a recent trend of successful challenges by generic pharmaceutical companies. ...

Major proposed changes to FIRB regime
Insight 05 Jun 2020

On 5 June 2020 the Federal Treasurer announced major proposed changes to Australia's FIRB regime to address national security risks and ensure greater compliance with FIRB approval conditions. ...

Dollars and sense: the evolution of executive remuneration practices
Insight 30 Sep 2020

The need for robust executive remuneration frameworks is becoming increasingly important as companies tackle the challenges arising out of the COVID-19 pandemic, a heightened regulatory environment and the need to strike the right balance with executives to drive and reward conduct and performance t ...

COVID-19 and continuous disclosure: how you get ready
Insight 10 Mar 2020

It is critical that listed entities understand how COVID-19 is likely to impact their businesses and are prepared to make necessary disclosures to the ASX. To date, the majority of ASX-listed entities have not made any disclosure in relation to COVID-19. In this update we have set out a number of scenarios that should be considered by listed clients as part of the proper and ongoing assessment of the need for disclosure under the ASX Listing Rules. ...

Refine

From
To